Literature DB >> 2543512

Microsomal lipid peroxidation induced by adriamycin, epirubicin, daunorubicin and mitoxantrone: a comparative study.

G F Vile1, C C Winterbourn.   

Abstract

Rat-liver microsomes and NADPH could reduce Adriamycin, epirubicin and daunorubicin to their free radical forms, which enhanced peroxidation of microsomal lipids less than 2-fold in air but 3- to 5-fold at a pO2 of 4 mmHg. Mitoxantrone was not reduced by microsomes and had no effect on microsomal peroxidation. Daunorubicin caused more lipid peroxidation than similar concentrations of either Adriamycin or epirubicin, which were equally efficient. In each case peroxidation was iron-dependent and could be catalysed by ferritin. The antioxidants beta-carotene and alpha-tocopherol inhibited lipid peroxidation at low or high pO2. The dose-for-dose difference in the cardiotoxicity of epirubicin compared with Adriamycin is not explained by its effect on microsomal lipid peroxidation. However, the lower incidence of cardiotoxicity with mitoxantrone may be a consequence of its inability to form free radical species and promote lipid peroxidation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2543512     DOI: 10.1007/bf00263129

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  28 in total

1.  Stimulation of microsomal NADPH oxidation by quinone group-containing anticancer chemicals.

Authors:  K Handa; S Sato
Journal:  Gan       Date:  1976-08

2.  Adriamycin stimulated superoxide formation in submitochondrial particles.

Authors:  W S Thayer
Journal:  Chem Biol Interact       Date:  1977-12       Impact factor: 5.192

3.  The electrochemical reduction of 1,4-bis-(2-[(2-hydroxyethyl)-amino] ethylamino)-anthracenedione and daunomycin: biochemical significance in superoxide formation.

Authors:  B K Sinha; A G Motten; K W Hanck
Journal:  Chem Biol Interact       Date:  1983-03       Impact factor: 5.192

4.  Redox activities of antitumor anthracyclines determined by microsomal oxygen consumption and assays for superoxide anion and hydroxyl radical generation.

Authors:  J H Peters; G R Gordon; D Kashiwase; J W Lown; S F Yen; J A Plambeck
Journal:  Biochem Pharmacol       Date:  1986-04-15       Impact factor: 5.858

5.  Release of iron from ferritin by cardiotoxic anthracycline antibiotics.

Authors:  C E Thomas; S D Aust
Journal:  Arch Biochem Biophys       Date:  1986-08-01       Impact factor: 4.013

6.  Serum lipid peroxides in rats treated chronically with adriamycin.

Authors:  W S Thayer
Journal:  Biochem Pharmacol       Date:  1984-07-15       Impact factor: 5.858

7.  Inhibitory effects of anthracenedione antineoplastic agents on hepatic and cardiac lipid peroxidation.

Authors:  E D Kharasch; R F Novak
Journal:  J Pharmacol Exp Ther       Date:  1983-08       Impact factor: 4.030

8.  Stimulation of mouse heart and liver microsomal lipid peroxidation by anthracycline anticancer drugs: characterization and effects of reactive oxygen scavengers.

Authors:  E G Mimnaugh; T E Gram; M A Trush
Journal:  J Pharmacol Exp Ther       Date:  1983-09       Impact factor: 4.030

9.  Cardiac disease induced by chronic adriamycin administration in dogs and an evaluation of vitamin E and selenium as cardioprotectants.

Authors:  J F Van Vleet; V J Ferrans; W E Weirich
Journal:  Am J Pathol       Date:  1980-04       Impact factor: 4.307

10.  Comparative cardiac oxygen radical metabolism by anthracycline antibiotics, mitoxantrone, bisantrene, 4'-(9-acridinylamino)-methanesulfon-m-anisidide, and neocarzinostatin.

Authors:  J H Doroshow; K J Davies
Journal:  Biochem Pharmacol       Date:  1983-10-01       Impact factor: 5.858

View more
  6 in total

1.  Evaluation of incorporation characteristics of mitoxantrone into unilamellar liposomes and analysis of their pharmacokinetic properties, acute toxicity, and antitumor efficacy.

Authors:  R A Schwendener; H H Fiebig; M R Berger; D P Berger
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 2.  Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.

Authors:  D Faulds; J A Balfour; P Chrisp; H D Langtry
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

3.  Iron- and ascorbic acid-induced lipid peroxidation in renal microsomes isolated from rats treated with platinum compounds.

Authors:  J Hannemann; J Duwe; K Baumann
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

4.  Development of the model of rat isolated perfused heart for the evaluation of anthracycline cardiotoxicity and its circumvention.

Authors:  P Pouna; S Bonoron-Adèle; G Gouverneur; L Tariosse; P Besse; J Robert
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

Review 5.  Demystifying the secret mission of enhancers: linking distal regulatory elements to target genes.

Authors:  Lijing Yao; Benjamin P Berman; Peggy J Farnham
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-10-08       Impact factor: 8.250

Review 6.  Comparison of Anticancer Drug Toxicities: Paradigm Shift in Adverse Effect Profile.

Authors:  Debasish Basak; Scott Arrighi; Yasenya Darwiche; Subrata Deb
Journal:  Life (Basel)       Date:  2021-12-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.